Vitau Blog · Apr 2026
Explains Mounjaro (tirzepatide) as a prescription injectable for glucose control in adults with type 2 diabetes and notes cardiovascular-risk reduction indications.
Subscription pharmacy for patients with chronic diseases in LatAm.
Public company, workplace, funding, and market signals
Vitau is a Monterrey-based Mexican digital pharmacy for chronic-disease patients. Its core product is a subscription medicine-delivery service with reminder automation, insurance-reimbursement support, and B2B tooling for clinics and hospitals.
Primary product
Subscription pharmacy for chronic-disease medications and related health products
Founded
2019
Headquarters
Monterrey, Nuevo León, Mexico
Team size
11-50
Industry
Wellness and Fitness Services
Sub-industry
Digital pharmacy / subscription pharmacy
Offices
0 jobs at Vitau
Check back later for new openings
Business model
Stage
Seed
Total raised
$4.9M
Latest round
Seed · Nov 2021
Latest amount
$1.6M
Leadership
Co-Founder and CEO
Co-Founder
Head of Operations and Finance
Investors
Mission-driven and patient-centered; public values emphasize collaboration and humility, responsibility, and continuous learning, plus user-friendly technology and customer service.
Compensation
No public salary bands or compensation policy were found.
Pricing
Subscription pharmacy with e-commerce checkout; partner/clinic platform and API services for healthcare providers.
Differentiators
Technology
Customers
Competitors
Estimated revenue
Approx. USD 2.3M ARR (2024 estimate)
Estimated monthly visits
59.1K
Traffic estimate as of Jun 2026
Vitau Blog · Apr 2026
Explains Mounjaro (tirzepatide) as a prescription injectable for glucose control in adults with type 2 diabetes and notes cardiovascular-risk reduction indications.
Vitau Blog · Apr 2026
Explains azathioprine as an immunosuppressant used for certain autoimmune diseases and transplant rejection prevention.
El Horizonte · May 2022
Describes Vitau as a 100% digital pharmacy with home delivery, recurring-order reminders, insurance reimbursement help, and loyalty discounts.
Vitau Blog · Jun 2021
Founder-story post describing Vitau’s origin as a response to chronic patients’ difficulty obtaining medicines and regular refills.
Disruptivo.tv · May 2020
Profiles Vitau’s recurring-medication model, early pre-seed financing led by Toro Ventures, and Y Combinator S2019 participation.